Format

Send to

Choose Destination
JAMA. 2016 Sep 6;316(9):962-9. doi: 10.1001/jama.2016.11046.

Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.

Author information

1
University of California, San Francisco.
2
Group Health Research Institute, Seattle, Washington.
3
University of Iowa, Iowa City.
4
University of Wisconsin-Madison.
5
Columbia University, New York, New York.
6
State University of New York Upstate Medical University, Syracuse.
7
Pima County Department of Health, Tucson, Arizona.
8
Independent consultant, Washington, DC.
9
Duke University, Durham, North Carolina.
10
Fairfax Family Practice Residency, Fairfax, Virginia11Virginia Commonwealth University, Richmond.
11
Yale University, New Haven, Connecticut.
12
University of Alabama at Birmingham.
13
University of California, Los Angeles.
14
University of Washington, Seattle.
15
Brown University, Providence, Rhode Island.
16
University of Texas at Austin.

Abstract

IMPORTANCE:

Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and mortality of active disease is the identification and treatment of latent tuberculosis infection (LTBI) to prevent progression to active disease.

OBJECTIVE:

To issue a current US Preventive Services Task Force (USPSTF) recommendation on screening for LTBI.

EVIDENCE REVIEW:

The USPSTF reviewed the evidence on screening for LTBI in asymptomatic adults seen in primary care, including evidence dating from the inception of searched databases.

FINDINGS:

The USPSTF found adequate evidence that accurate screening tests for LTBI are available, treatment of LTBI provides a moderate health benefit in preventing progression to active disease, and the harms of screening and treatment are small. The USPSTF has moderate certainty that screening for LTBI in persons at increased risk for infection provides a moderate net benefit.

CONCLUSIONS AND RECOMMENDATION:

The USPSTF recommends screening for LTBI in populations at increased risk. (B recommendation).

Summary for patients in

PMID:
27599331
DOI:
10.1001/jama.2016.11046
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center